July 30, 2013

Trends in the use of antiasthmatic medications in Morocco (1999–2010)

Open Access
Research

Trends in the use of antiasthmatic medications in Morocco (1999–2010)

Imane Ghanname1*Samir Ahid1Ghizlane Berrada1Abdelmjid Belaiche2Mohamed Hassar1 and Yahya Cherrah1
For all author emails, please log on.
SpringerPlus 2013, 2:82 doi:10.1186/2193-1801-2-82
Published: 5 March 2013

Abstract

Background

Asthma is a big public health problem in Morocco. The drug therapy existing in Morocco is currently insufficient because of the low purchasing power and the low health insurance coverage available to the average citizen in Morocco. In this study we evaluated the consumption of antiasthmatics in Morocco during the period 1999–2010, the classes of used drugs and the generics’ market share.

Methods

We used sales data from the Moroccan subsidiaries of the IMS Health “Intercontinental Marketing Service”. The consumption volume was converted to Defined Daily Doses (DDDs).

Results

During 1999–2010, antiasthmatics’s consumption increased from 3.91 to 14.47 DDD per 1000 inhabitants per day. In 2010, the association Beta-2-mimetic-Glucocorticosteroids were the most consumed (8.53 DDD/1000 Inhabitants/day) followed by the short-acting inhaled Beta-2-mimetic (4 DDD/1000 Inhabitants/day) and inhaled Glucocorticosteroids alone accounted for 1.13 DDD/1000 Inhabitants/day. The largest consumption share in volume was held by the short-acting inhaled Beta-2-mimetic (42%) followed by the combination Beta-2-mimetic-Glucocorticosteroids (38%). Between 1999 and 2010, the market for generic antiasthmatics increased from 1.84 to 2.18 DDD/1000 Inhabitants/day. The ratio of the monthly average cost of treatment to the minimum wage in Morocco decreased from 10.8% in 1999 to 7.11% in 2010.

Conclusion

Antiasthmatics’ consumption in Morocco has undergone significant changes between 1999 and 2010. However, the availability of these drugs expressed as the Average Monthly Expenditure/Guaranteed Minimum Wage ratio improved. Despite this, the use of antiasmathics in Morocco remains low.
Keywords: 
Antiasthmatic; Average monthly expenditure; Consumption; Defined Daily Dose (DDD); Morocco

Viewing options

No comments:

Post a Comment